Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Leelasiri A"'
Autor:
W. Prayoonwiwat, W. Jandamnernpong, K. Satayasoontorn, C. Laoruangroj, K. Prayongratana, A. Leelasiri
Publikováno v:
HemaSphere. 3:818
Publikováno v:
Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 97(6)
Insulin resistance is commonly observed in uremic patients. Angiotensin II receptor blockers (ARB) are reported to act as insulin sensitizers in the animal model of hypertension and hypertensive patients. The authors investigated the effects of valsa
Autor:
Stanley E. Graber, Sanya Sukpanichnant, John B. Cousar, Robert D. Collins, John P. Greer, Apichai Leelasiri
Publikováno v:
Human Pathology. 25:308-318
Diagnostic criteria in myeloma have not been completely standardized or tested for accuracy; furthermore, marrow findings of prognostic value have not been clearly identified. We studied 176 patients with myeloma to determine the relative value of ma
Autor:
T. Numbenjapon, N. Mahapo, A. Leelasiri, W. Mongkonsritragoon, W. Prayoonwiwat, Chantrapa Sriswasdi, R. Pornvipavee
Publikováno v:
International journal of laboratory hematology. 30(5)
Bone marrow (BM) examination is the gold standard test in discriminating between hyperdestructive thrombocytopenia and hypoproductive thrombocytopenia. However, this procedure is invasive. Mean platelet volume (MPV) is simple and may be used as an al
Autor:
Tanomsri, Srichaikul, Sompone, Punyagupta, Termkiat, Kanchanapoom, Chow, Chanokovat, Kanchit, Likittanasombat, Apichai, Leelasiri
Publikováno v:
Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 91(1)
A 46 year old woman who presented with severe multiorgans involvement including liver brain, cardio-pulmonary failure, gastrointestinal bleeding, progressive cytopenia, DIC and hemophagocytic syndrome during the convalescent phase of Dengue type II h
Autor:
Tontanai, Numbenjapon, Chantrapa, Sriswasdi, Wichean, Mongkonsritragoon, Apichai, Leelasiri, Wichai, Prayoonwiwat
Publikováno v:
Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 85(11)
Standard-dose (2 mg/day) oral granisetron seems to have more antiemetic efficacy than that of high-dose (0.5-1 mg/kg/dose) metoclopramide in moderately emetogenic chemotherapy. However, the cost of oral granisetron is much higher than that of metoclo
Autor:
Tanin Intragumtornchai, Suporn Chuncharunee, Wichai Prayoonwiwat, Arnuparp Lekhakula, Boonsom Chaimongkol, Yataro Yoshida, K. Chansung, Apichai Leelasiri
Publikováno v:
International journal of hematology. 74(2)
The objective of this study was to determine the hematopoietic effects and toxicity of low-dose granulocyte colony-stimulating factor (G-CSF) in myelodysplastic syndrome (MDS) patients with neutropenia. Recombinant human G-CSF (Lenograstim) was admin
Myelodysplastic syndromes in Thailand: a retrospective pathologic and clinical analysis of 117 cases
Autor:
Saengsuree Jootar, Apichai Leelasiri, Wichai Prayoonwiwat, Kanchana Chansung, Nipha Suwanwela, Daratana Swasdikul, Suporn Chancharunee, Tanin Intragumtornchai, Boonsom Chaimongkol, Yataro Yoshida
Publikováno v:
Leukemia research. 22(5)
To gain more insight into the understanding of myelodysplastic syndromes (MDS) as they occur in Thailand, a retrospective clinicopathologic analysis was conducted in patients (age > 15 years) diagnosed as MDS from January 1992 to December 1996 at the
Autor:
S, Chuncharunee, S, Jootar, A, Leelasiri, N, Archararit, W, Prayoonwiwat, W, Mongkonsritragoon, P, Polvicha, T, Srichaikul
Publikováno v:
Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 80
Concentrations of tumor necrosis factor alpha (TNF-alpha) in serum were measured in 17 Thai men infected with Plasmodium falciparum malarial infections to determine whether they were affected by severity of infections or exchange transfusions. Twelve
Publikováno v:
Bone marrow transplantation. 15(3)
We performed a sequential study comparing two regimens, cyclosporine-methotrexate (CsA-MTX) and cyclosporine-methotrexate-methylprednisolone (CsA-MTX-MP) for graft-versus-host disease (GVHD) prophylaxis in patients undergoing matched unrelated donor